AstraZeneca said its cancer-treatment drugs when used following chemotherapy treatment showed positive late-stage trial results for endometrial cancer patients.
Share:
More In Business
Stellantis Lays Off 400 Workers As Automakers Look Toward the Future with EVs
Jeep maker Stellantis announced their planned layoffs as it deals with the transition from combustion engines to electric vehicles.
#KateGate is Over: Princess of Wales Announces She Has Cancer
The video announcement Friday came after weeks of speculation spread on social media about her whereabouts and health since she was hospitalized in January for unspecified abdominal surgery.
Big Business This Week: The Future Is Electric, Reddit IPO Goes Boom, Lower Interest Rates on the Horizon
Reddit comes out swinging, Biden seeks to slash vehicle emissions and Trump seeks a get cash quick deal.
Combining ‘Immersive Media’ and Philanthropy
Chip Giller, co-founder, and Amy Seidenwurm, Chief of Programs and Strategy at Agog: The Immersive Media Institute, discuss how the organization uses the virtual world to make real change.
Equality for Women at Work ‘Starts with Self Advocacy’
Luminary founder and CEO Cate Luzio shares some of the company’s latest Women’s History Month events and why there’s so much to celebrate about women in the workplace.
Should You Take a Promotion with No Pay Increase?
WSJ reporter Ray Smith breaks down why more companies are offering ‘dry’ promotions – a responsibility or title bump with no pay raise – and the pros and cons of accepting them.
5 Money-Making Apps to Boost Your Bank Account
Find your dollars dwindling? These apps can help.
Justice Department Sues Apple, Alleging It Illegally Monopolized the Smartphone Market
Apple says a Justice Department antitrust lawsuit accusing it of engineering an illegal monopoly in smartphones in the U.S. is “wrong on the facts and the law.”
Reddit’s IPO Hits the NYSE
As Reddit shares begin trading at the NYSE, ‘Einstein of Wall Street’ Peter Tuchman breaks down the social platform’s debut and what it means for the overall IPO market in 2024.
